These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11242412)

  • 1. Cost-effectiveness of colorectal cancer screening.
    Donohoe M
    JAMA; 2001 Jan 24-31; 285(4):407; author reply 408. PubMed ID: 11242412
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for colorectal cancer: the light at the end of the tunnel.
    Caprilli R; Taddei G
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):109-13. PubMed ID: 9646188
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness studies fan colonoscopy debate.
    Newman L
    J Natl Cancer Inst; 2000 Nov; 92(22):1796-8. PubMed ID: 11078753
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of colorectal cancer screening.
    Budenholzer B; Welch HG
    JAMA; 2001 Jan 24-31; 285(4):407; author reply 408. PubMed ID: 11242411
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening and surveillance for colorectal cancer.
    Schnoll-Sussman F; Markowitz AJ; Winawer SJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):10-21. PubMed ID: 11049028
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it time to recommend screening for colorectal cancer?
    Lieberman D; Sleisenger MH
    Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening of colorectal cancer: indications and recommendations for a practical procedure].
    Porschen R
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):705-10. PubMed ID: 8237065
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 9. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening.
    Cher DJ
    J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial.
    Whynes DK
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):155-65. PubMed ID: 10612015
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 19. Colorectal cancer screening: potential pitfalls.
    Duggan J
    Aust Health Rev; 2001; 24(1):148-50. PubMed ID: 11357729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass screening for colorectal cancer: are we ready?
    Clayman CB
    JAMA; 1989 Jan; 261(4):609. PubMed ID: 2491895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.